This Fusion Animation reel features excerpts from diverse 3D medical animations focused on Oncology. It showcases treatments developed with the assistance of Machine Learning (AI), alongside visualizations of crucial intracellular changes in the MAPK pathway in cancer. The reel concludes by demonstrating angiogenesis and blood supply to tumors. This highlights our expertise in animating complex Intracellular Signaling, Biotech, and Tumor Microenvironment concepts.
Oncology Medical Animations
Cancer treatment visualised. Our oncology animations combine scientific rigor with captivating cinematic storytelling.
0:00
ONCOLOGY REEL: AI drug development, INTRACELLULAR PATHWAYS, AND ANGIOGENESIS
This Fusion Animation reel features excerpts from diverse 3D medical animations focused on Oncology. It showcases treatments developed with the assistance of Machine Learning (AI), alongside visualizations of crucial intracellular changes in the MAPK pathway in cancer. The reel concludes by demonstrating angiogenesis and blood supply to tumors. This highlights our expertise in animating complex Intracellular Signaling, Biotech, and Tumor Microenvironment concepts.
0:00
ERAP1 INHIBITION: A NOVEL STRATEGY TO ENHANCE CANCER IMMUNOVISIBILITY
This Fusion Animation uses 3D medical animation to detail a novel Immuno-Oncology strategy: enhancing cancer immunovisibility. We visualize how inhibiting the enzyme ERAP1 alters neoantigen presentation on MHC Class I. This modulation increases the display of specific neoantigens, making the tumour significantly more visible to the immune system for attack. This project showcases our expertise in complex Antigen Processing and Immunology concepts.
0:00
TUMOUR ANGIOGENESIS: VISUALIZING THE ANGIOGENIC SWITCH AND TUMOUR VASCULARIZATION
This Fusion Animation uses 3D medical animation to detail Tumour Angiogenesis, a key process in cancer pathology. We visualize the angiogenic switch, triggered by factors released from cancerous cells due to hypoxia. This stimulates the proliferation of new blood vessels that supply the tumour. The video also shows tumour cells co-opting existing vessels. This highlights our expertise in complex Oncology and Vascularization concepts.
0:00
LURBINECTEDIN MOA: DUAL INHIBITION OF TRANSCRIPTION FOR SMALL-CELL LUNG CANCER
This Fusion Animation uses 3D medical animation to detail the innovative Mechanism of Action (MOA) of Lurbinectedin for aggressive Small-Cell Lung Cancer (SCLC). We visualize its dual antitumoral mechanism: blocking RNA Polymerase II and causing DNA double-strand breaks for apoptotic cell death. The video also shows Lurbinectedin disrupting the Tumor Microenvironment by targeting Tumor Associated Macrophages. This showcases our expertise in Oncology and Transcription Inhibition.
OUR CLIENTS
Can we bring you clarity?